|Articles|January 15, 2003
- BioPharm International-01-01-2003
- Volume 16
- Issue 1
Rethinking the Economics of Chromatography: New Technologies and Hidden Costs
Author(s)Tim N. Warner, Sam Nuchumson
by Tim N. Warner and Sam Nuchumson, Pall Life Sciences If the hidden expenses associated with laboratory purchases ? labor, cleaning, buffers, validation, time delays ? are identified, reduced processing costs, higher throughput, and accelerated time-to-market are possible. This comparison between resin and membrane chromatography helps shed light on some hidden costs.
Advertisement
Articles in this issue
almost 23 years ago
Biotech World: Canada's Supreme Court says "No" to Harvard Mousealmost 23 years ago
Guest Editorial: At the Governance Crossroadalmost 23 years ago
Reducing Costs by Facility Designalmost 23 years ago
Guidelines for Optimization and Scale-Up in Preparative Chromatographyalmost 23 years ago
Survival Strategies: Board Compensation Changing with the TimesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement